MIZUHO MEDY CO.,LTD. Logo

MIZUHO MEDY CO.,LTD.

Develops rapid diagnostic tests & gene analyzers for clinical, research & agricultural markets.

4595 | T

Overview

Corporate Details

ISIN(s):
JP3885900005
LEI:
Country:
Japan
Address:
鳥栖市藤木町5番地の4
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Mizuho Medy Co., Ltd. is an in vitro diagnostics (IVD) company that specializes in the research, development, manufacturing, and sale of diagnostic products. The company's portfolio focuses on rapid immunoassay and nucleic acid amplification technologies, with a significant emphasis on point-of-care testing (POCT) reagents. Its product lines include the 'Quick Chaser' series for detecting infectious diseases like influenza, RSV, and SARS-CoV-2, and the 'Quick Checker' series for hormonal tests such as pregnancy and ovulation. In addition to diagnostic kits, Mizuho Medy develops instruments like fully automated gene analyzers. The company serves the clinical, research, and agricultural markets and operates under the ISO 13485 quality management standard for medical devices.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-08 06:06
Interim Report
確認書
Japanese 8.7 KB
2025-08-08 06:04
Interim Report
半期報告書-第49期(2025/01/01-2025/12/31)
Japanese 204.8 KB
2025-04-02 06:17
Post-Annual General Meeting Information
臨時報告書
Japanese 25.9 KB
2025-03-31 03:44
Governance Information
内部統制報告書-第48期(2024/01/01-2024/12/31)
Japanese 22.5 KB
2025-03-31 03:41
Registration Form
確認書
Japanese 8.7 KB
2025-03-31 03:37
Annual Report
有価証券報告書-第48期(2024/01/01-2024/12/31)
Japanese 931.6 KB
2024-08-09 06:11
Regulatory News Service
確認書
Japanese 8.7 KB
2024-08-09 06:09
Interim Report
半期報告書-第48期(2024/01/01-2024/12/31)
Japanese 209.8 KB
2024-05-10 06:07
Report Publication Announcement
確認書
Japanese 8.7 KB
2024-05-10 06:06
Quarterly Report
四半期報告書-第48期第1四半期(2024/01/01-2024/03/31)
Japanese 169.5 KB
2024-04-01 09:48
Post-Annual General Meeting Information
臨時報告書
Japanese 21.6 KB
2024-03-29 02:02
Governance Information
内部統制報告書-第47期(2023/01/01-2023/12/31)
Japanese 22.5 KB
2024-03-29 01:59
Registration Form
確認書
Japanese 8.7 KB
2024-03-29 01:56
Annual Report
有価証券報告書-第47期(2023/01/01-2023/12/31)
Japanese 967.0 KB
2023-11-10 05:09
Report Publication Announcement
確認書
Japanese 8.7 KB

Automate Your Workflow. Get a real-time feed of all MIZUHO MEDY CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MIZUHO MEDY CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MIZUHO MEDY CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Bioengineering solutions to accelerate life sciences research, from gene synthesis to cell lines.
South Korea
355690
aTYR PHARMA INC Logo
Developing novel medicines for fibrosis and inflammation using tRNA synthetase biology.
United States of America
ATYR
Aura Biosciences, Inc. Logo
Developing virus-like therapies to selectively destroy solid tumors in ocular & urologic oncology.
United States of America
AURA
Aurinia Pharmaceuticals Inc. Logo
Biopharma developing therapies for autoimmune and kidney diseases like lupus nephritis.
United States of America
AUPH
AURORA CANNABIS INC Logo
A global producer and seller of medical and recreational cannabis and derivative products.
United States of America
ACB
Autolus Therapeutics plc Logo
Develops programmed CAR T-cell therapies for cancer and autoimmune diseases.
United States of America
AUTL
AVADEL PHARMACEUTICALS PLC Logo
Develops once-at-bedtime therapies for adults with narcolepsy using innovative drug delivery.
United States of America
AVDL
Avidity Biosciences, Inc. Logo
Pioneering targeted RNA therapies that treat the root cause of rare muscle diseases.
United States of America
RNA
Axsome Therapeutics, Inc. Logo
Biopharma company developing novel therapies for central nervous system (CNS) conditions.
United States of America
AXSM
AYTU BIOPHARMA, INC Logo
Specialty pharma advancing innovative medicines for CNS diseases like MDD and ADHD.
United States of America
AYTU

Talk to a Data Expert

Have a question? We'll get back to you promptly.